Volume 73, Issue 12, Pages (June 2008)

Slides:

Advertisements

Similar presentations

Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic.

Advertisements

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Volume 66, Issue 3, Pages (September 2004)

Acute interstitial nephritis

Marlies Noordzij, Kitty J. Jager Kidney International

Mitchell H. Rosner, W. Kline Bolton Kidney International

End-stage renal disease in developing countries

Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis James F. Medcalf, Kevin P.G.

Volume 83, Issue 3, Pages (March 2013)

Diffuse vascular calcification in a dialysis patient

Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.

Parapelvic cysts leading to a diagnosis of Fabry disease

The Case ∣ Acute renal failure and anemia

Volume 66, Issue 3, Pages (September 2004)

Acute interstitial nephritis

Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States Austin G. Stack, Bhamidipati V.R.

Whitney A. High, MD, MEng, Reed A

Infected kidney cysts Kidney International

Reassessment of the care of the patient with chronic kidney disease

Fibrin plug Kidney International Volume 78, Issue 9, (November 2010)

Volume 75, Issue 11, Pages (June 2009)

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Volume 77, Issue 1, Pages 6-8 (January 2010)

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating Wim Van Biesen, Achim Jörres Kidney International

Volume 85, Issue 3, Pages (March 2014)

Volume 80, Issue 9, Pages (November 2011)

Erik H. Strøm, Michael J. Mihatsch Kidney International

Comorbidity and confounding in end-stage renal disease

Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought Nicolas Rognant, Maurice Laville Kidney.

Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing? Gautam R. Shroff, Charles A. Herzog

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Volume 74, Issue 3, Pages (August 2008)

Volume 81, Issue 2, Pages (January 2012)

CYP24A1 mutation leading to nephrocalcinosis

Volume 70, Issue 11, Pages (December 2006)

Acute myocardial infarction in patients with end-stage renal disease

Volume 70, Issue 12, Pages (December 2006)

Quiz page December 2004 American Journal of Kidney Diseases

Blood pressure targets in hemodialysis patients

Volume 73, Issue 12, Pages (June 2008)

Volume 76, Issue 6, Pages (September 2009)

Yijian Huang, Rebecca Zhang, Steven D. Culler, Nancy G. Kutner

The third World Kidney Day: Looking back and thinking forward

Effects of hemodialysis on cardiac function

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Volume 80, Issue 5, Pages (September 2011)

Alternate-day dialysis may be needed for hemodialysis patients

Nephrology Crossword: Peritoneal Dialysis

Volume 87, Issue 1, Pages (January 2015)

Nephrology Crossword: Glomerulonephritis

Lynda Anne Szczech, Ira L. Lazar Kidney International

Volume 69, Issue 10, Pages (May 2006)

Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival.

Vanishing renal artery disease: a segmental arterial mediolysis story

Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes Sr. Anne B. Bakewell, Rob M. Higgins, Mair.

Peter J. Conlon, Mark A. Little, Karen Pieper, Daniel B. Mark

Should the targeted value of the phosphate be reviewed in the normal range from the viewpoint of vascular calcification? Keitaro Yokoyama, Hiraku Yoshida,

The Iranian model of living renal transplantation

Volume 87, Issue 1, Pages (January 2015)

Volume 80, Issue 10, Pages (November 2011)

Charles A. Herzog Kidney International

Perirenal lymphatic filariasis presenting as chyluria during pregnancy

End-stage renal disease from renal metastases

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Hemodialysis access failure: a call to action—revisited

Stephen Pastan, J. Michael Soucie, William M. McClellan

Presentation transcript:

Volume 73, Issue 12, Pages 1413-1418 (June 2008) Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis S. Swaminathan, W.A. High, J. Ranville, T.D. Horn, K. Hiatt, M. Thomas, H.H. Brown, S.V. Shah Kidney International Volume 73, Issue 12, Pages 1413-1418 (June 2008) DOI: 10.1038/ki.2008.76 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 Nephrogenic systemic fibrosis and limb ischemia after magnetic resonance angiography. New-onset limb ischemia (a) and nephrogenic systemic fibrosis (b) 1 month after exposure to gadolinium contrast media in a patient with end-stage renal disease on peritoneal dialysis. A significant amount of gadolinium (49 μg g-1) was detected in the aorta 36 days after gadolinium-based contrast exposure. Kidney International 2008 73, 1413-1418DOI: (10.1038/ki.2008.76) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Coronary artery disease with vascular gadolinium deposition. (a) Coronary artery disease in a patient with nephrogenic systemic fibrosis with CD34-positive cells. Appreciable quantities of gadolinium were present in the vessel wall. (b and c) Iron particles demonstrated in the vessel wall using electron scanning microscopy. Kidney International 2008 73, 1413-1418DOI: (10.1038/ki.2008.76) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 3 Myocardial fibrosis in a patient with nephrogenic systemic fibrosis and recurrent cardiac arrythmias. Appreciable quantities of gadolinium (442 μg g-1) were present in the myocardial tissues. Kidney International 2008 73, 1413-1418DOI: (10.1038/ki.2008.76) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 4 X-ray fluorescence microprobe for detection of gadolinium in the myocardium of an NSF patient with myocardial fibrosis shown in Figure 3. The tissue demonstrates strong gadolinium emission spectra. Kidney International 2008 73, 1413-1418DOI: (10.1038/ki.2008.76) Copyright © 2008 International Society of Nephrology Terms and Conditions